| Literature DB >> 35534865 |
Guo Zhang1, Shi-Qi Guo1, Si-Yuan Yin1, Wang-Ding Yuan1, Ping Chen1, Ji-Il Kim2, Hui-Ying Wang1, Hai-Bo Zhou3,4, Abraham J Susswein5, Bong-Kiun Kaang2, Jian Jing6,7,8.
Abstract
Neuropeptides act mostly on a class of G-protein coupled receptors, and play a fundamental role in the functions of neural circuits underlying behaviors. However, physiological functions of some neuropeptide receptors are poorly understood. Here, we used the molluscan model system Aplysia and microinjected the exogenous neuropeptide receptor apATRPR (Aplysia allatotropin-related peptide receptor) with an expression vector (pNEX3) into Aplysia neurons that did not express the receptor endogenously. Physiological experiments demonstrated that apATRPR could mediate the excitability increase induced by its ligand, apATRP (Aplysia allatotropin-related peptide), in the Aplysia neurons that now express the receptor. This study provides a definitive evidence for a physiological function of a neuropeptide receptor in molluscan animals.Entities:
Keywords: Aplysia; Electrophysiology; G-protein coupled receptors; Neuronal excitability; Neuropeptide; Plasmid microinjection
Mesh:
Substances:
Year: 2022 PMID: 35534865 PMCID: PMC9082908 DOI: 10.1186/s13041-022-00929-4
Source DB: PubMed Journal: Mol Brain ISSN: 1756-6606 Impact factor: 4.041
Fig. 1apATRP increased the excitability of B1/B2 neurons that were exogenously expressed with the receptor apATRPR. a, b apATRP increased B8 excitability at 10–5 M but not at 10–6 M (F(3, 6) = 14.89, p < 0.01, n = 3 individual neurons from three preparations). Bonferroni post hoc tests: *p < 0.05, **p < 0.01. Error bars, SE. c, d apATRP had no significant effect on B1/B2 excitability (F(3, 9) = 1.00, p > 0.05, n = 4 individual neurons from four preparations). Error bars, SE. e The caudal surface of a buccal ganglion viewed with a regular light source. B1/B2 and other neurons on the left side were microinjected with plasmids pNEX3-apATRPR and pNEX3-EGFP, and B1/B2 and other neurons on the right side were microinjected with only plasmid pNEX3-EGFP. Arrows indicate the neurons injected with plasmids and expressed the EGFP protein (showed bright fluorescence under a fluorescence microscope, see panel f). Arrowheads indicate the neurons injected with plasmids but did not express the EGFP protein. f B1/B2 neurons on both sides showed bright fluorescence (green, arrows) under a fluorescence microscope. The left B1/B2 neuron expressed apATRPR and EGFP, and the right B1/B2 neuron expressed EGFP. Other neurons marked with arrowheads in (e) did not express injected genes. g, h A magnified view of the injected neurons in (f) showing left B1/B2 neuron (g) and right B1/B2 neuron (h). Scale bar in f: 500 μm (scale bar in f is for e and f); Scale bar in h: 200 μm (scale bar in h is for g and h). i, j At 10–6 M and 10–5 M, apATRP increased B1/B2 excitability (F(3, 9) = 44.84, p < 0.0001, n = 4 individual neurons from three preparations), which expressed the receptor apATRPR. Bonferroni post hoc tests: ***p < 0.001. Error bars, SE. k, l apATRP had no significant effects on B1/B2 neurons that do not express the receptor apATRPR (F(3, 6) = 1.60, p > 0.05, n = 3 individual neurons from three preparations). Bars in a, c, i and k denote current injections. Control groups and wash groups in a, c, i, k were perfused with high divalent saline only, whereas the experimental groups in a, c, i, k were perfused with the neuropeptide apATRP dissolved in high divalent saline